Lexaria Bioscience Corp. (LEXX)
0.9801
-0.05
(-4.84%)
USD |
NASDAQ |
Apr 20, 11:28
Lexaria Bioscience SG&A Expense (Quarterly) : 0.00 for Feb. 28, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 2.18M |
| Aurinia Pharmaceuticals, Inc. | 29.26M |
| Edesa Biotech, Inc. | 1.217M |
| Xenon Pharmaceuticals, Inc. | 22.07M |
| ProMIS Neurosciences, Inc. | 1.404M |